AspenBio Pharma, Inc. reported results today from the Company's recently completed AppyScore(TM) ELISA-based pivotal clinical trial. The study was designed to evaluate the utility of the AppyScore blood-based test in aiding in the evaluation of patients suspected of having acute appendicitis.
